125 related articles for article (PubMed ID: 38185269)
21. The Concordant Disruption of B7/CD28 Immune Regulators Predicts the Prognosis of Oral Carcinomas.
Chang SR; Chou CH; Liu CJ; Lin YC; Tu HF; Chang KW; Lin SC
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983005
[TBL] [Abstract][Full Text] [Related]
22. Programmed cell death-ligand 1 expression in oral squamous cell carcinoma is associated with an inflammatory phenotype.
Satgunaseelan L; Gupta R; Madore J; Chia N; Lum T; Palme CE; Boyer M; Scolyer RA; Clark JR
Pathology; 2016 Oct; 48(6):574-80. PubMed ID: 27590194
[TBL] [Abstract][Full Text] [Related]
23. APE1 facilitates PD-L1-mediated progression of laryngeal and hypopharyngeal squamous cell carcinoma.
Wang J; Lun L; Jiang X; Wang Y; Li X; Du G; Wang J
Int Immunopharmacol; 2021 Aug; 97():107675. PubMed ID: 33964809
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of PD-L2 expression in patients with oral squamous cell carcinoma-A comparison to the PD-L1 expression profile.
Weber M; Wehrhan F; Baran C; Agaimy A; Büttner-Herold M; Kesting M; Ries J
Cancer Med; 2019 Mar; 8(3):1124-1134. PubMed ID: 30659749
[TBL] [Abstract][Full Text] [Related]
25. MiR-524 suppressed the progression of oral squamous cell carcinoma by suppressing Metadherin and NF-κB signaling pathway in OSCC cell lines.
Chang XS; Zhu J; Yang T; Gao Y
Arch Oral Biol; 2021 May; 125():105090. PubMed ID: 33676362
[TBL] [Abstract][Full Text] [Related]
26. PD-L1-Mediated Immunosuppression in Oral Squamous Cell Carcinoma: Relationship With Macrophage Infiltration and Epithelial to Mesenchymal Transition Markers.
Wu T; Tang C; Tao R; Yong X; Jiang Q; Feng C
Front Immunol; 2021; 12():693881. PubMed ID: 34552581
[TBL] [Abstract][Full Text] [Related]
27. FOXM1-Mediated Regulation of Reactive Oxygen Species and Radioresistance in Oral Squamous Cell Carcinoma Cells.
Takeshita H; Yoshida R; Inoue J; Ishikawa K; Shinohara K; Hirayama M; Oyama T; Kubo R; Yamana K; Nagao Y; Gohara S; Sakata J; Nakashima H; Matsuoka Y; Nakamoto M; Hirayama M; Kawahara K; Takahashi N; Hirosue A; Kuwahara Y; Fukumoto M; Toya R; Murakami R; Nakayama H
Lab Invest; 2023 May; 103(5):100060. PubMed ID: 36801643
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin-induced programmed cell death ligand-2 expression is associated with metastasis ability in oral squamous cell carcinoma.
Sudo S; Kajiya H; Okano S; Sasaki M; Katsumata Y; Ohno J; Ikebe T; Hiraki A; Okabe K
Cancer Sci; 2020 Apr; 111(4):1113-1123. PubMed ID: 32012401
[TBL] [Abstract][Full Text] [Related]
29. PD-1 Carried on Small Extracellular Vesicles Leads to OSCC Metastasis.
Zhang LZ; Yang JG; Xia HF; Huang J; Liu HM; Wu M; Liu B; Wang WM; Chen G
J Dent Res; 2023 Jul; 102(7):795-805. PubMed ID: 37246810
[TBL] [Abstract][Full Text] [Related]
30. Predictive factors in the treatment of oral squamous cell carcinoma using PD-1/PD-L1 inhibitors.
Gao A; Pan X; Yang X; Lin Z
Invest New Drugs; 2021 Aug; 39(4):1132-1138. PubMed ID: 33594603
[TBL] [Abstract][Full Text] [Related]
31. Significant association of increased PD-L1 and PD-1 expression with nodal metastasis and a poor prognosis in oral squamous cell carcinoma.
Maruse Y; Kawano S; Jinno T; Matsubara R; Goto Y; Kaneko N; Sakamoto T; Hashiguchi Y; Moriyama M; Toyoshima T; Kitamura R; Tanaka H; Oobu K; Kiyoshima T; Nakamura S
Int J Oral Maxillofac Surg; 2018 Jul; 47(7):836-845. PubMed ID: 29395669
[TBL] [Abstract][Full Text] [Related]
32. Protein Kinase D3 Promotes the Reconstruction of OSCC Immune Escape Niche Via Regulating MHC-I and Immune Inhibit Molecules Expression.
Lv D; Chen J; Kang Y; Luo M; Chen H; Cui B; Wang L; Wang J; Zhou X; Feng Y; Huang L; Zhang P
J Immunother; 2021 Nov-Dec 01; 44(9):339-347. PubMed ID: 34545012
[TBL] [Abstract][Full Text] [Related]
33. Deubiquitination and stabilization of programmed cell death ligand 1 by ubiquitin-specific peptidase 9, X-linked in oral squamous cell carcinoma.
Jingjing W; Wenzheng G; Donghua W; Guangyu H; Aiping Z; Wenjuan W
Cancer Med; 2018 Aug; 7(8):4004-4011. PubMed ID: 29992764
[TBL] [Abstract][Full Text] [Related]
34. miR-626 Inhibition Enhanced the Radiosensitivity to Oral Squamous Cell Carcinoma via the Downregulation of Nuclear Factor Kappa-B Signaling.
Ma J; Na S; Wang P; Li J; He S; Liu F
Cancer Biother Radiopharm; 2024 Mar; 39(2):144-152. PubMed ID: 35549438
[No Abstract] [Full Text] [Related]
35. UBE2L3 promotes squamous cell carcinoma progression in the oral cavity and hypopharynx via activating the NF-κB signaling by increasing IκBα degradation.
Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
Cell Biol Int; 2022 May; 46(5):806-818. PubMed ID: 35128752
[TBL] [Abstract][Full Text] [Related]
36. PD-1/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma.
Kujan O; Agag M; Smaga M; Vaishnaw Y; Idrees M; Shearston K; Farah CS
Pathology; 2022 Jun; 54(4):409-416. PubMed ID: 34872754
[TBL] [Abstract][Full Text] [Related]
37. Fat mass and obesity-associated protein regulates arecoline-exposed oral cancer immune response through programmed cell death-ligand 1.
Li X; Chen W; Gao Y; Song J; Gu Y; Zhang J; Cheng X; Ai Y
Cancer Sci; 2022 Sep; 113(9):2962-2973. PubMed ID: 35289035
[TBL] [Abstract][Full Text] [Related]
38. Prognostic and clinicopathological significance of PD-L1 overexpression in oral squamous cell carcinoma: A systematic review and comprehensive meta-analysis.
Lenouvel D; González-Moles MÁ; Ruiz-Ávila I; Gonzalez-Ruiz L; Gonzalez-Ruiz I; Ramos-García P
Oral Oncol; 2020 Jul; 106():104722. PubMed ID: 32330687
[TBL] [Abstract][Full Text] [Related]
39. Regulation of PD-L1 expression in a high-grade invasive human oral squamous cell carcinoma microenvironment.
Hirai M; Kitahara H; Kobayashi Y; Kato K; Bou-Gharios G; Nakamura H; Kawashiri S
Int J Oncol; 2017 Jan; 50(1):41-48. PubMed ID: 27922697
[TBL] [Abstract][Full Text] [Related]
40. Triptolide suppresses oral cancer cell PD-L1 expression in the interferon-γ-modulated microenvironment in vitro, in vivo, and in clinical patients.
Kuo CS; Yang CY; Lin CK; Lin GJ; Sytwu HK; Chen YW
Biomed Pharmacother; 2021 Jan; 133():111057. PubMed ID: 33378962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]